# Thymulin FAQ: Zinc, Benefits, Dosage, Side Effects, and Safety

> Thymulin FAQ: what it is, why it needs zinc, how it differs from thymosin alpha-1, the immune and lung findings, the research doses, and the honest safety gaps. Plain answers, cited.

The questions people actually ask about thymulin, answered fast and cited — with the honest caveats kept loud.

## Has thymulin been studied for asthma?

Yes, in mice. A single intratracheal dose of thymulin-expressing plasmids in mucus-penetrating nanoparticles, given after experimental allergic asthma was fully established, normalized key lung pathologies — chronic inflammation, fibrosis, mechanical dysregulation — at 20 days [7]. A separate DNA-nanoparticle approach prevented airway remodeling [10]. Animal-model findings only, not an asthma treatment.

## What is thymulin?

Thymulin (serum thymic factor; FTS/FTS-Zn) is a zinc-dependent thymic nonapeptide hormone produced exclusively by thymic epithelial cells and biologically active only when bound to zinc in a 1:1 ratio [1][2]. It is studied as a research peptide and is not FDA-approved for any use.

## What is thymulin peptide?

A linear nonapeptide — sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — that becomes the active hormone thymulin when one zinc ion binds per molecule [1][2]. It is handled as a research peptide for laboratory use, with molecular formula C33H54N12O15 and a molecular weight near 858.9 Da.

## Is thymulin the same as serum thymic factor (FTS)?

They are the same peptide in different states. Serum thymic factor (FTS) is the original name; the zinc-bound, biologically active form was named thymulin (FTS-Zn) [1]. The zinc-free apopeptide is inactive — so the difference is the bound zinc ion, not the peptide sequence [1][2].

## How is thymulin different from thymosin alpha-1?

Thymulin is a distinct zinc-dependent nonapeptide; thymosin alpha-1 is a separate, longer thymic peptide [1][4]. They are chemically and pharmacologically different compounds and should not be conflated. Thymulin is also distinct from thymosin beta-4, thymopentin, and thymalin — different molecules with different data [4].

## What is the amino acid sequence of thymulin?

The sequence is pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (written <Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn), a nine-residue peptide [2]. Its molecular formula is C33H54N12O15, and it becomes biologically active when zinc binds in a 1:1 ratio [1][2].

## Why does thymulin need zinc to work?

Binding one zinc ion gives the peptide a specific active conformation; chelating zinc (for example with Chelex) abolishes activity, which is restored by zinc at a 1:1 metal-to-peptide ratio [1]. The zinc-free apopeptide is inactive [1]. Zinc is the conformational key that switches thymulin on [2].

## What does thymulin do in the body?

As an endogenous thymic hormone, thymulin has been studied in T-lymphocyte differentiation and immune modulation, in anti-inflammatory signaling, and in a bidirectional thymus-neuroendocrine axis where it acts on the pituitary [4]. These are research findings describing its biology, not clinical claims.

## What are the benefits of thymulin peptide?

In animal and in-vitro models, thymulin has been associated with anti-inflammatory effects — lower pro-inflammatory cytokines and NF-kB suppression [6] — and with immune modulation [4]. No human benefit is established; the findings are described in study species, not as outcomes in people.

## What are the benefits of thymulin?

Reported research effects span immune (T-cell) modulation [4], anti-inflammatory action [6], neuroendocrine signaling [4], and protection across several lung models [7][9]. All are preclinical or limited-human findings — none is an approved indication or a demonstrated human benefit.

## Does thymulin boost the immune system?

In research models, thymulin drives T-cell differentiation [4] and, in chickens, enhanced lung NK-cell cytotoxicity against a virus in a dose-dependent way [13]. Circulating thymulin also tracks zinc status and declines with age [3]. These are model findings, not a human immune-boosting claim.

## Does thymulin reduce inflammation?

In LPS-treated mice, thymulin lowered plasma pro-inflammatory cytokines and inducible heat-shock proteins and modulated NF-kB and SAPK/JNK signaling [6]. In a rat lung model it suppressed IL-6 and the p38 pathway [8]. Animal-model anti-inflammatory findings only, not a human anti-inflammatory therapy.

## Can thymulin help with autoimmune disease?

In rodent autoimmune models, thymulin modulated inflammatory responses, and early human work used a synthetic analog (nonathymulin) in rheumatoid arthritis [4]. These are research findings and small, dated studies — not a treatment claim for any autoimmune disease in people.

## Does thymulin have anti-aging effects?

Circulating thymulin falls with age and zinc deficiency, and in aged mice zinc repletion restored thymic function and thymulin secretion [3]. This links thymulin to immunosenescence in models — the age-related immune decline — but it is not a proven anti-aging effect in people [2][3].

## Is thymulin studied for pain relief?

In rodents, thymulin and its analog PAT reduced inflammatory and neuroinflammatory hyperalgesia, with thymulin's CNS anti-inflammatory and analgesic activity documented in the literature [4]. This is preclinical analgesia research in animal models — not a pain treatment for humans.

## What is the dosage of thymulin peptide?

There is no established human dose. Research doses are reported only as study findings — for example, nanogram-to-low-microgram amounts per animal in rodents [4][13]. They describe what was administered in a given species and are never guidance for a person to follow.

## How is thymulin administered in research?

Routes studied include intraperitoneal, subcutaneous, intracerebroventricular, intratracheal (gene therapy), intramuscular (vector), topical (a small zinc-thymulin pilot), and in vitro [4][5][7][11]. These describe laboratory studies and delivery strategies, not a human protocol.

## Is thymulin taken as an injection?

In animal research, thymulin has been given parenterally — for example intraperitoneal and subcutaneous injection [11][12][14]. It is a research peptide with no approved human formulation, so this describes study methods, not dosing guidance for people.

## What doses of thymulin were used in animal studies?

Examples: 0.1-1 microg intracerebroventricular and 1-1000 ng intraperitoneal in rodent neuroinflammation models [4]; about 100 ng/kg/day subcutaneous in a rat pulmonary-hypertension model [8]; and 3-100 microg/day subcutaneous for radioprotection in mice [14]. Reported as study findings only.

## Is there a thymulin supplement?

No. Thymulin is not a dietary supplement; it is a research peptide and is not FDA-approved [4]. Because its activity depends on zinc, much research studies zinc status instead — as the determinant of how much active thymulin circulates [2][3].

## What is the half-life of thymulin?

As a small peptide, native thymulin has a short circulating half-life, but a precise human pharmacokinetic half-life is not well established in the public literature [4]. Gene-therapy approaches were developed specifically to sustain circulating thymulin levels [5][7].

## What are the side effects of thymulin peptide?

Human safety data are sparse and dated, and several human studies used a synthetic analog (nonathymulin) rather than native thymulin [4]. A small topical zinc-thymulin pilot was reported as well-tolerated, but no comprehensive human side-effect profile for thymulin exists [4].

---

A high-energy reading of the thymulin record drawn panel by panel — the zinc power-up that switches the nonapeptide on, the T-cell and lung findings, and the missing human trials all inked from the published studies; no clinic behind the page and nothing here dosed, dispensed, or sold.